Company: ARMP
Filing Date: 2025-12-01
Form Type: 8-K
Source: 0001104659-25-117387
Chunk: 1

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 8-K
Item: Item 1.01
Chunk 1
---
 Placement Shares under the Sales Agreement. Under the terms of the Sales Agreement, the Company will not issue or sell
through Jones such number or dollar amount of shares of Common Stock that would exceed, among other metrics set forth in the Sales Agreement,
(i) the number or dollar amount of shares of Common Stock registered and available on the Registration Statement or (ii) the
number of authorized but unissued shares of Common Stock.

The Sales Agreement contains customary representations, warranties,
and agreements by the Company and customary indemnification rights and obligations of the parties.

The Company or Jones may terminate the offering of Placement Shares
upon three days’ notice to the other party.

The foregoing description of the Sales Agreement is not complete and
is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed herewith as Exhibit 1.1
to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the opinion of Ballard Spahr LLP relating to
the legality of the issuance and sale of the Placement Shares in the offering is attached as Exhibit 5.1 hereto.

This Current Report on Form 8-K shall not constitute an offer
to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of
the securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or other jurisdiction.